ヘパリン市場：製品タイプ、投与経路、用途、エンドユーザー別-2023-2030年の世界予測

ヘパリンの世界市場は、2023年に78億5,030万米ドル、CAGR 11.12%で大きく成長し、2030年には164億9,824万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のヘパリン市場を評価するために不可欠です。事業戦略や製品満足度などの主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.ヘパリンの世界市場規模および予測は？

2.予測期間中、世界のヘパリン市場を形成するCOVID-19の阻害要因と影響は？

3.ヘパリンの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.ヘパリンの世界市場における競争戦略は？

5.ヘパリンの世界市場における技術動向と規制の枠組みは？

6.ヘパリンの世界市場における主要ベンダーの市場シェアは？

7.ヘパリンの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 静脈血栓塞栓症および心血管障害の増加
    • 抗凝固剤の需要が高い
    • 深部静脈血栓症（DVT）の発生率の上昇
  • 抑制要因
    • ヘパリンに関連する副作用
  • 機会
    • 新薬開発と合成医薬品の開発に重点を置いた製薬の改善ヘパリン
    • 医療費の増加と患者の意識の向上
  • 課題
    • 豚の入手可能性の問題
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 ヘパリン市場：製品タイプ別

• 低分子量ヘパリン
• 超低分子量ヘパリン
• 分割されていないヘパリン

第7章 ヘパリン市場：投与経路別

• 静注
• 皮下注射

第8章 ヘパリン市場：用途別

• 臨床試験
• 病気の治療
• 医療機器

第9章 ヘパリン市場：エンドユーザー別

• 血液・幹細胞バンク
• 病院

第10章 南北アメリカのヘパリン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のヘパリン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのヘパリン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. HEPARIN MARKET RESEARCH PROCESS
• FIGURE 2. HEPARIN MARKET SIZE, 2022 VS 2030
• FIGURE 3. HEPARIN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
• FIGURE 5. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2030 (%)
• FIGURE 6. HEPARIN MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. HEPARIN MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 8. HEPARIN MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. HEPARIN MARKET DYNAMICS
• FIGURE 10. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. HEPARIN MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. HEPARIN MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. HEPARIN MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. HEPARIN MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. HEPARIN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. HEPARIN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 5. HEPARIN MARKET SIZE, BY LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. HEPARIN MARKET SIZE, BY ULTRA-LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. HEPARIN MARKET SIZE, BY UNFRACTIONATED HEPARIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 9. HEPARIN MARKET SIZE, BY IV INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. HEPARIN MARKET SIZE, BY SUBCUTANEOUS INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. HEPARIN MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. HEPARIN MARKET SIZE, BY DISEASE TREATMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. HEPARIN MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. HEPARIN MARKET SIZE, BY BLOOD & STEM CELL BANK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. HEPARIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. CANADA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. CANADA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES HEPARIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. CHINA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. CHINA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. INDIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 59. INDIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. TAIWAN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. THAILAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. VIETNAM HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. DENMARK HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EGYPT HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. FINLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. FRANCE HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. GERMANY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. ISRAEL HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. ITALY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ITALY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. ITALY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. NETHERLANDS HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. NIGERIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NORWAY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. POLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. POLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 144. POLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. QATAR HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. QATAR HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 148. QATAR HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. RUSSIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. SAUDI ARABIA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH AFRICA HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SPAIN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SWEDEN HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SWITZERLAND HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. TURKEY HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. UNITED KINGDOM HEPARIN MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM HEPARIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM HEPARIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM HEPARIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. HEPARIN MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 187. HEPARIN MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 188. HEPARIN MARKET LICENSE & PRICING

The Global Heparin Market is forecasted to grow significantly, with a projected USD 7,850.30 million in 2023 at a CAGR of 11.12% and expected to reach a staggering USD 16,498.24 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Heparin Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Heparin Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product Type, market is studied across Low Molecular Weight Heparin, Ultra-Low Molecular Weight Heparin, and Unfractionated Heparin. The Unfractionated Heparin is projected to witness significant market share during forecast period.

Based on Route of Administration, market is studied across IV Injection and Subcutaneous Injection. The IV Injection is projected to witness significant market share during forecast period.

Based on Application, market is studied across Clinical trials, Disease treatment, and Medical devices. The Disease treatment is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Blood & Stem Cell Bank and Hospitals. The Blood & Stem Cell Bank is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Heparin Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Heparin Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Heparin Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Heparin Market?

4. What is the competitive strategic window for opportunities in the Global Heparin Market?

5. What are the technology trends and regulatory frameworks in the Global Heparin Market?

6. What is the market share of the leading vendors in the Global Heparin Market?

7. What modes and strategic moves are considered suitable for entering the Global Heparin Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Heparin Market, by Product Type, 2022 vs 2030
• 4.3. Heparin Market, by Route of Administration, 2022 vs 2030
• 4.4. Heparin Market, by Application, 2022 vs 2030
• 4.5. Heparin Market, by End-User, 2022 vs 2030
• 4.6. Heparin Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growth in number of venous thromboembolism and cardiovascular disorders
    • 5.1.1.2. High demand for anticoagulants
    • 5.1.1.3. Rising incidences for deep vein thrombosis (DVT)
  • 5.1.2. Restraints
    • 5.1.2.1. Side effects associated with Heparin
  • 5.1.3. Opportunities
    • 5.1.3.1. Improved pharmaceutical focus on new drug development and development of synthetic heparin
    • 5.1.3.2. Increasing health expenditure and awareness among patients
  • 5.1.4. Challenges
    • 5.1.4.1. Porcine availability issues
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Heparin Market, by Product Type

• 6.1. Introduction
• 6.2. Low Molecular Weight Heparin
• 6.3. Ultra-Low Molecular Weight Heparin
• 6.4. Unfractionated Heparin

7. Heparin Market, by Route of Administration

• 7.1. Introduction
• 7.2. IV Injection
• 7.3. Subcutaneous Injection

8. Heparin Market, by Application

• 8.1. Introduction
• 8.2. Clinical trials
• 8.3. Disease treatment
• 8.4. Medical devices

9. Heparin Market, by End-User

• 9.1. Introduction
• 9.2. Blood & Stem Cell Bank
• 9.3. Hospitals

10. Americas Heparin Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Heparin Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Heparin Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing